Related Experiment Video
Updated: Aug 20, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Bacteria in the treatment of cancer
John Lin1, Eugene Lin, John Nemunaitis
1Mary Crowley Medical Research Center, Texas Oncology PA, 3535 Worth Street, Dallas, TX 75246, USA.
Abstract:
Incidental observations of cancer regression following spontaneous bacterial infection have led to the preclinical development of bacteria as potential therapeutics in the treatment of cancer. A variety of natural and gene-modified bacterial species have now been explored as potential cancer treatments. The selectivity of bacterial species towards cancer will be discussed, direct bacterial oncolytic activity will be summarized and the use of bacteria as gene and/or protein delivery vehicles will be described. Preclinical and early clinical results presented indicate a high safety profile and demonstrate clear anticancer activity, thereby justifying further investigation of bacteria as a therapeutic approach in the treatment of cancer.
Insights
Bacteria show promise as cancer treatments, with preclinical and early clinical results demonstrating safety and effectiveness. Further research is warranted to explore bacteria as a novel therapeutic strategy for cancer.
Area of Science:
- Oncology
- Microbiology
- Biotechnology
Background:
- Cancer regression observed after bacterial infections prompted research into bacteria as cancer therapeutics.
- Various natural and genetically modified bacterial species are being investigated for cancer treatment.
Purpose of the Study:
- To discuss bacterial selectivity towards cancer.
- To summarize direct bacterial oncolytic activity.
- To describe bacteria as gene/protein delivery vehicles for cancer therapy.
Main Methods:
- Review of preclinical and early clinical studies on bacterial cancer therapy.
- Analysis of bacterial species' tumor-homing capabilities.
- Evaluation of direct bacterial cancer cell killing mechanisms.
Main Results:
- Bacterial cancer therapies exhibit a high safety profile in early trials.
- Clear evidence of anticancer activity has been demonstrated.
- Bacteria can be engineered as effective delivery systems for therapeutic genes or proteins.
Conclusions:
- Bacteria represent a viable and promising therapeutic approach for cancer treatment.
- Further investigation into bacterial-based cancer therapies is strongly supported by current data.
- Bacterial selectivity and oncolytic potential offer unique advantages in oncology.
Related Concept Videos
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

